STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8
Clinical trials for STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo therapy for pancreatic tumors enters human trials
Disease control Recruiting nowThis early-phase trial tests whether combining two targeted drugs—sunitinib malate and lutetium Lu 177 dotatate (Lutathera)—is safe and effective for people with advanced pancreatic neuroendocrine tumors. About 24 participants will receive the combination to find the best dose an…
Matched conditions: STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Could chemo after surgery keep pancreatic cancer at bay?
Disease control Recruiting nowThis study looks at whether giving two chemotherapy drugs (capecitabine and temozolomide) after surgery can stop high-risk pancreatic neuroendocrine tumors from coming back. About 141 people who had their tumor removed will either get the chemo or just be watched. The goal is to …
Matched conditions: STAGE III PANCREATIC NEUROENDOCRINE TUMOR AJCC V8
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated May 15, 2026 11:56 UTC